Bernard-Soulier syndrome is a bleeding disorder associated with abnormal platelets, which are blood cell fragments involved in blood clotting. In affected individuals, platelets are unusually large and fewer in number than usual (a combination known as macrothrombocytopenia). People with Bernard-Soulier syndrome tend to bruise easily and have an increased risk of nosebleeds (epistaxis). They may also experience abnormally heavy or prolonged bleeding following minor injury or surgery or even without trauma (spontaneous bleeding). In some affected individuals, bleeding under the skin causes tiny red or purple spots on the skin called petechiae. Women with Bernard-Soulier syndrome often have heavy or prolonged menstrual periods (menorrhagia).
Bernard-Soulier syndrome is estimated to occur in 1 in 1 million individuals; however, some doctors think the condition is underdiagnosed and may be more common.
Bernard-Soulier syndrome is caused by mutations in one of three genes: GP1BA, GP1BB, or GP9. The proteins produced from these genes are pieces (subunits) of a protein complex called glycoprotein (GP)Ib-IX-V. This complex is found on the surface of platelets and plays an important role in blood clotting.
The GPIb-IX-V complex can attach (bind) to a protein called von Willebrand factor, fitting together like a lock and its key. Von Willebrand factor is found on the inside surface of blood vessels, particularly when there is an injury. Binding of the GPIb-IX-V complex to von Willebrand factor allows platelets to stick to the blood vessel wall at the site of the injury. These platelets form clots, plugging holes in the blood vessels to help stop bleeding.
Most mutations in GP1BA, GP1BB, or GP9 prevent the formation of the GPIb-IX-V complex on the surface of platelets. Other mutations impair the complex's interaction with von Willebrand factor. All of these mutations impair clot formation, which leads to the excessive bleeding characteristic of Bernard-Soulier syndrome.
Most cases of Bernard-Soulier syndrome are inherited in an autosomal recessive pattern, which means both copies of the GP1BA, GP1BB, or GP9 gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene. Although most people with only one copy of the mutated gene do not show signs and symptoms of the condition, some have platelets that are slightly larger than normal or very mild bleeding abnormalities.
Rare cases of Bernard-Soulier syndrome caused by mutations in the GP1BA or GP1BB gene are inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. These individuals inherit the condition from an affected parent.
These resources address the diagnosis or management of Bernard-Soulier syndrome:
These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:
- bleeding disorder, platelet-type, 1
- deficiency of platelet glycoprotein 1b
- giant platelet syndrome
- glycoprotein Ib, platelet, deficiency of
- hemorrhagioparous thrombocytic dystrophy
- macrothrombocytopenia, familial Bernard-Soulier type
- platelet glycoprotein Ib deficiency
- von Willebrand factor receptor deficiency
- Disease InfoSearch: Bernard-Soulier syndrome type C
- Disease InfoSearch: Bernard-Soulier syndrome, type A
- Disease InfoSearch: Bernard-Soulier syndrome, type A2, autosomal dominant
- Johns Hopkins Medicine: What are Platelets and Why are They Important?
- MalaCards: bernard-soulier syndrome type a
- MalaCards: bernard-soulier syndrome, type a2
- MalaCards: bernard-soulier syndrome, type c
- Merck Manual Consumer Version: How Blood Clots
- Orphanet: Bernard-Soulier syndrome